These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26908101)

  • 1. Cochrane corner: early statin therapy in acute coronary syndromes--what is the clinical benefit?
    Nordmann A; Schwartz G; Vale N; Bucher HC; Briel M
    Heart; 2016 May; 102(9):653-4. PubMed ID: 26908101
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipid-lowering therapy in acute coronary syndromes.
    Sacks FM
    JAMA; 2001 Apr; 285(13):1758-60. PubMed ID: 11277832
    [No Abstract]   [Full Text] [Related]  

  • 3. Anti-inflammatory effect of atorvastatin (80 mg) in unstable angina pectoris and non-Q-wave acute myocardial infarction.
    Correia LC; Spósito AC; Lima JC; Magalhães LP; Passos LC; Rocha MS; D'Oliveira A; Esteves JP
    Am J Cardiol; 2003 Aug; 92(3):298-301. PubMed ID: 12888137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can early treatment with atorvastatin (Lipitor) improve the outcome of patients with acute coronary syndromes?
    Johnson K; Breen WJ
    J Fam Pract; 2001 Jul; 50(7):572. PubMed ID: 11485701
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.
    Schwartz GG; Olsson AG; Ezekowitz MD; Ganz P; Oliver MF; Waters D; Zeiher A; Chaitman BR; Leslie S; Stern T;
    JAMA; 2001 Apr; 285(13):1711-8. PubMed ID: 11277825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine statin treatment after acute coronary syndromes?
    Acevedo M; Sprecher DL; Lauer MS; Francis G
    Am Heart J; 2002 Jun; 143(6):940-2. PubMed ID: 12075242
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute statin treatment in reducing risk after acute coronary syndrome: the MIRACL (Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering) Trial.
    Ahsan CH; Shah A; Ezekowitz M
    Curr Opin Cardiol; 2001 Nov; 16(6):390-3. PubMed ID: 11704711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of assessment of lipophilic vs. hydrophilic statin therapy in acute myocardial infarction (the ALPS-AMI) study.
    Kashima Y; Izawa A; Aizawa K; Koshikawa M; Kasai H; Tomita T; Kumazaki S; Tsutsui H; Koyama J; Ikeda U
    J Cardiol; 2009 Aug; 54(1):76-9. PubMed ID: 19632524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design of the Myocardial Ischemia Reduction With Aggressive Cholesterol lowering (MIRACL) Study that evaluates atorvastatin in unstable angina pectoris and in non-Q-wave acute myocardial infarction.
    Ghali JK
    Am J Cardiol; 1998 Sep; 82(5):703. PubMed ID: 9732912
    [No Abstract]   [Full Text] [Related]  

  • 10. Intensive versus moderate lipid lowering with statins in acute coronary syndromes.
    Farmer JA
    Curr Atheroscler Rep; 2005 Mar; 7(2):85-6. PubMed ID: 15727720
    [No Abstract]   [Full Text] [Related]  

  • 11. Atorvastatin for acute coronary syndromes.
    Schwartz GG; Olsson AG; Ezekowitz MD; Ganz P; Oliver MF; Waters D; Zeiher A; Chaitman BR
    JAMA; 2001 Aug; 286(5):533-5. PubMed ID: 11476650
    [No Abstract]   [Full Text] [Related]  

  • 12. Early atorvastatin therapy improves cardiac function in patients with acute myocardial infarction.
    Teshima Y; Yufu K; Akioka H; Iwao T; Anan F; Nakagawa M; Yonemochi H; Takahashi N; Hara M; Saikawa T
    J Cardiol; 2009 Feb; 53(1):58-64. PubMed ID: 19167639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Following the ASCOT Study. A statin for every hypertensive patient?].
    MMW Fortschr Med; 2003 Apr; 145(16):8. PubMed ID: 14606391
    [No Abstract]   [Full Text] [Related]  

  • 14. What is the role of intensive cholesterol lowering in the treatment of acute coronary syndromes?
    Waters DD; Hsue PY
    Am J Cardiol; 2001 Oct; 88(7B):7J-16J. PubMed ID: 11595193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-reactive protein levels and outcomes after statin therapy.
    Clearfield M
    Curr Atheroscler Rep; 2006 Jan; 8(1):8-9. PubMed ID: 16455006
    [No Abstract]   [Full Text] [Related]  

  • 16. Atorvastatin for acute coronary syndromes.
    Wierzbicki AS; Mikhaildis DP; Reynolds TR
    JAMA; 2001 Aug; 286(5):532-3; author reply 533-5. PubMed ID: 11476649
    [No Abstract]   [Full Text] [Related]  

  • 17. [Statins and unstable angina: MIRACL].
    Puel J
    Ann Endocrinol (Paris); 2001 Feb; 62(1 Pt 2):145-8. PubMed ID: 11240417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The year in non-ST-segment elevation acute coronary syndromes.
    Giugliano RP; Braunwald E
    J Am Coll Cardiol; 2006 Jul; 48(2):386-95. PubMed ID: 16843191
    [No Abstract]   [Full Text] [Related]  

  • 19. [Statin therapy in patients with acute coronary syndrome. "Prove-it" study].
    von Schacky C
    Internist (Berl); 2004 Dec; 45(12):1437-9. PubMed ID: 15448925
    [No Abstract]   [Full Text] [Related]  

  • 20. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study.
    Kinlay S; Schwartz GG; Olsson AG; Rifai N; Leslie SJ; Sasiela WJ; Szarek M; Libby P; Ganz P;
    Circulation; 2003 Sep; 108(13):1560-6. PubMed ID: 12975259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.